Trisalus Life Sciences Stock Beta

TLSIW Stock   1.00  0.07  7.53%   
TriSalus Life Sciences fundamentals help investors to digest information that contributes to TriSalus Life's financial success or failures. It also enables traders to predict the movement of TriSalus Stock. The fundamental analysis module provides a way to measure TriSalus Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TriSalus Life stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

TriSalus Life Sciences Company Beta Analysis

TriSalus Life's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current TriSalus Life Beta

    
  0.5  
Most of TriSalus Life's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TriSalus Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

TriSalus Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for TriSalus Life is extremely important. It helps to project a fair market value of TriSalus Stock properly, considering its historical fundamentals such as Beta. Since TriSalus Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TriSalus Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TriSalus Life's interrelated accounts and indicators.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, TriSalus Life Sciences has a Beta of 0.497. This is 42.21% lower than that of the Health Care Equipment & Supplies sector and 52.21% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.

TriSalus Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TriSalus Life's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TriSalus Life could also be used in its relative valuation, which is a method of valuing TriSalus Life by comparing valuation metrics of similar companies.
TriSalus Life is currently under evaluation in beta category among its peers.
As returns on the market increase, TriSalus Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding TriSalus Life is expected to be smaller as well.

TriSalus Fundamentals

About TriSalus Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze TriSalus Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TriSalus Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TriSalus Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TriSalus Stock Analysis

When running TriSalus Life's price analysis, check to measure TriSalus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TriSalus Life is operating at the current time. Most of TriSalus Life's value examination focuses on studying past and present price action to predict the probability of TriSalus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TriSalus Life's price. Additionally, you may evaluate how the addition of TriSalus Life to your portfolios can decrease your overall portfolio volatility.